By Scientia Professor Matthew Colm Kiernan

Journal articles

Krishnan AV; Kiernan MC, 2006, 'Axonal function and activity-dependent excitability changes in myotonic dystrophy', Muscle and Nerve, 33, pp. 627 - 636

Kiernan MC, 2006, 'Back to the future: Excitability studies take on a new clinical role', Clinical Neurophysiology, 117, pp. 712 - 713

Wang NE; Kiernan M; Golzari M; Gisondi MA, 2006, 'Characteristics of pediatric patients at risk of poor emergency department aftercare', ACADEMIC EMERGENCY MEDICINE, 13, pp. 840 - 847, http://dx.doi.org/10.1197/j.aem.2006.04.021

Kiernan MC; Talman P; Henderson RD; Harris R, 2006, 'Establishment of an Australian motor neurone disease registry', Medical Journal of Australia, 184, pp. 367 - 368

Nogajski J; Engel S; Kiernan MC, 2006, 'Focal and generalized peripheral nerve dysfunction in spinal cord-injured patients', Journal of Clinical Neurophysiology, 23, pp. 273 - 279

Krishnan AV; Phoon R; Pussell BA; Charlesworth JA; Bostock H; Kiernan MC, 2006, 'Ischaemia induces paradoxical changes in axonal excitability in end-stage kidney disease', Brain, 129, pp. 1585 - 1592

Krishnan AV; Phoon R; Pussell BA; Charlesworth JA; Bostock H; Kiernan MC, 2006, 'Neuropathy, axonal Na+/K+ pump function and activity-dependent excitability changes in end-stage kidney disease', Clinical Neurophysiology, 117, pp. 992 - 999

Winhammar J; Joffe D; Simmul R; Schoeffel R; Kiernan MC; Rowe DB, 2006, 'Nocturnal hypoxia in motor neuron disease is not predicted by standard respiratory function tests', Internal Medicine Journal, 36, pp. 419 - 422

Vucic O; Kiernan MC, 2006, 'Novel threshold tracking techniques suggest that cortical hyperexcitability is an early feature of motor neuron disease', Brain, 129, pp. 2436 - 2446

Krishnan AV; Goldstein D; Friedlander ML; Kiernan MC, 2006, 'Oxaliplatin and axonal Na+ channel function in vivo', Clinical Cancer Research, 12, pp. 4481 - 4484

Martin AC; Friedlander ML; Kiernan MC, 2006, 'Paraneoplastic mononeuritis multiplex in non-small-cell lung carcinoma', Journal of Clinical Neuroscience, 13, pp. 595 - 598

Zoing M; Burke D; Pamphlett R; Kiernan MC, 2006, 'Riluzole therapy for motor neurone disease: An early Australian experience (1996-2002)', Journal of Clinical Neuroscience, 13, pp. 78 - 83

Krishnan AV; Phoon R; Pussell BA; Charlesworth JA; Kiernan MC, 2006, 'Sensory nerve excitability and neuropathy in end stage kidney disease', Journal of Neurology Neurosurgery and Psychiatry, 77, pp. 548 - 551

Kiernan MC; Krishnan AV, 2006, 'The pathophysiology of oxaliplatin-induced neurotoxicity', Current Medicinal Chemistry: Cardiovascular and Hematological Agents, 13, pp. 2901 - 2907

Kiernan M, 2005, 'News from neurology', JOURNAL OF CLINICAL NEUROSCIENCE, 12, pp. 974 - 975, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000234351700032&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Kiernan M, 2005, 'Assessing fitness to drive', JOURNAL OF CLINICAL NEUROSCIENCE, 12, pp. 847 - 847, http://dx.doi.org/10.1016/j.jocn.2005.08.003

Henderson RD; McCombe PA; Kiernan MC, 2005, 'Riluzole: A glimmer of hope in the treatment of motor neurone disease (multiple letters) [4]', Medical Journal of Australia, 183, pp. 164 - 165, http://dx.doi.org/10.5694/j.1326-5377.2005.tb06972.x

Kalapesi FB; Krishnan AV; Kiernan MC, 2005, 'Segmental facial anhidrosis and tonic pupils with preserved deep tendon reflexes: A novel autonomic neuropathy (vol 25, pg 7, 2005)', JOURNAL OF NEURO-OPHTHALMOLOGY, 25, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000229689000001&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Kiernan M, 2005, 'AAN neurology advanced trainee study weekend', JOURNAL OF CLINICAL NEUROSCIENCE, 12, pp. 370 - 370, http://dx.doi.org/10.1016/j.jocn.2005.03.005

Krishnan A; Phoon RK; Pussel B; Charlesworth JA; Bostock H; Kiernan MC, 2005, 'Abnormal sensory nerve excitability underlying the development of uraemic neuropathy', Journal of the Neurological Sciences, 238, pp. S189 - S190

Turner MA; Kiernan MD; McKechanie AG; Finch PJC; McManus FB; Neal LA, 2005, 'Acute military psychiatric casualties from the war in Iraq', BRITISH JOURNAL OF PSYCHIATRY, 186, pp. 476 - 479, http://dx.doi.org/10.1192/bjp.186.6.476

Kiernan MC; Isbister GK; Lin CS; Burke D; Bostock H, 2005, 'Acute tetrodotoxin-induced neurotoxicity after ingestion of puffer fish', Annals of Neurology, 57, pp. 339 - 348

Kiernan MC, 2005, 'Alterations in axonal sodium channel function in inherited epilepsy and neuropathy', Journal of the Neurological Sciences, 238, pp. S34 - S35

Krishnan AV; Phoon RK; Pussell BA; Charlesworth JA; Bostock H; Kiernan MC, 2005, 'Altered motor nerve excitability in end-stage kidney disease', Brain, 128, pp. 2164 - 2174

Krishnan AV; Kiernan MC, 2005, 'Altered nerve excitability properties in established diabetic neuropathy', Brain, 128, pp. 1178 - 1187

Winhammar J; Rowe DB; Henderson RD; Kiernan MC, 2005, 'Assessment of disease progression in motor neuron disease', Lancet Neurology, 4, pp. 229 - 238, http://www.sciencedirect.com/science/article/B6X3F-4FR39CB-N/2/16b79d4f58cf38009c22f3d1c2330119

Krishnan A; Phoon RK; Pussell BA; Charlesworth JA; Bostock H; Kiernan MC, 2005, 'Axonal dysfunction in uraemic neuropathy', Journal of the Neurological Sciences, 238, pp. S93 - S94

Thomas PS; Kiernan MC; Yates D, 2005, 'Cerebral nocardiosis', Internal Medicine Journal, 35, pp. 685 - 685

Krishnan AV; Lin CS; Kiernan MC, 2005, 'Excitability differences in lower-limb motor axons during and after ischemia', Muscle and Nerve, 31, pp. 205 - 213

Krishnan AV; Colebatch JG; Kiernan MC, 2005, 'Hypokalemic weakness in hyperaldosteronism: Activity-dependent conduction block', Neurology, 65, pp. 1309 - 1312

Kiernan MC; Krishnan AV; Lin CS; Burke D; Berkovic S, 2005, 'Mutation in the Na+ channel subunit SCN1B produces paradoxical changes in peripheral nerve excitability', Brain, 128, pp. 1841 - 1846

Isbister GK; Kiernan MC, 2005, 'Neurotoxic marine poisoning', Lancet Neurology, 4, pp. 219 - 228, http://www.sciencedirect.com/science/article/B6X3F-4FR39CB-M/2/eca458cfa97b799faaf40af8f62c7e3b

Krishnan AV; Goldstein D; Friedlander ML; Kiernan MC, 2005, 'Oxaliplatin-induced neurotoxicity and the development of neuropathy', Muscle and Nerve, 32, pp. 51 - 60

Kiernan M, 2005, 'Philip Geoffrey McManis (14 April 1953-17 September 2004)', JOURNAL OF CLINICAL NEUROSCIENCE, 12, pp. 111 - 111, http://dx.doi.org/10.1016/j.jocn.2004.11.002

Burke D; Kiernan M; Maxwell I, 2005, 'Proceedings of the 11th Biennial Clinical Neurophysiology Workshop of the Australian Association of Neurologists', Clinical Neurophysiology, 116, pp. e19 - e24, http://dx.doi.org/10.1016/j.clinph.2005.05.001

Kiernan MC, 2005, 'Riluzole: a glimmer of hope in the treatment of motor neurone disease', Medical Journal of Australia, 182, pp. 319 - 320

Kalapesi FB; Krishnan AV; Kiernan MC, 2005, 'Segmental facial anhidrosis and tonic pupils with preserved deep tendon reflexes: A novel autonomic neuropathy', Journal of Neuro - Ophthalmology, 25, pp. 5 - 8

Vucic S; Howells JA; Trevillion L; Kiernan MC, 2005, 'The utility of threshold tracking transcranial magnetic stimulation in assessing cortical excitability', Journal of the Neurological Sciences, 238, pp. S459 - S460

Krishnan AV; Pamphlett R; Burke D; Wills EJ; Kiernan MC, 2004, 'Cytoplasmic body myopathy masquerading as motor neuron disease', Muscle and Nerve, 30, pp. 667 - 672, http://www.sciencedirect.com/science/article/B6WVB-4DMWWWN-3M2/2/99a220d6f400fe51ab568e7c1f67b59f

Kiernan MC; Lin CS; Burke D, 2004, 'Differences in activity-dependent hyperpolarization in human sensory and motor axons', The Journal of Physiology, 558, pp. 341 - 349

Bostock H; Walters RJ; Andersen KV; Murray NM; Taube D; Kiernan MC, 2004, 'Has potassium been prematurely discarded as a contributing factor to the development of uraemic neuropathy?', Nephrology Dialysis Transplantation, 19, pp. 1054 - 1057

Kiernan MC; Bullpitt P; Chan JH, 2004, 'Mitochondrial dysfunction and rod-like lesions associated with administration of beta-2 adrenoceptor agonist formoterol', Neuromuscular Disorders, 14, pp. 375 - 377

Krishnan AV; Lin CS; Kiernan MC, 2004, 'Nerve excitability properties in lower-limb motor axons: evidence for a length-dependent gradient', Muscle and Nerve, 29, pp. 645 - 655

Kiernan MC; Baker M; Bostock H, 2003, 'Characteristics of late Na+ current in adult rat small sensory neurons', Neuroscience, 119, pp. 653 - 660

Neal LA; Kiernan M; Hill D; McManus F; Turner MA, 2003, 'Management of mental illness by the British Army', BRITISH JOURNAL OF PSYCHIATRY, 182, pp. 337 - 341, http://dx.doi.org/10.1192/bjp.182.4.337

Kiernan MC, 2003, 'Motor neurone disease: a Pandora`s box', Medical Journal of Australia, 178, pp. 311 - 312

Kiernan MC, 2002, 'Chapter 23 Pathophysiology of paraesthesiae', Supplements to Clinical Neurophysiology, 54, pp. 156 - 162, http://dx.doi.org/10.1016/S1567-424X(09)70443-X

Mercer K; Chiloeches A; Hüser M; Kiernan M; Marais R; Pritchard C, 2002, 'ERK signalling and oncogene transformation are not impaired in cells lacking A-Raf', ONCOGENE, 21, pp. 347 - 355, http://dx.doi.org/10.1038/sj.onc.1205101

Kiernan MC; Guglielmi JM; Kaji R; Murray NMF; Bostock H, 2002, 'Evidence for axonal membrane hyperpolarization in multifocal motor neuropathy with conduction block', Brain, 125, pp. 664 - 675, http://dx.doi.org/10.1093/brain/awf041

Kiernan MC; Walters RJL; Andersen KV; Taube D; Murray NMF; Bostock H, 2002, 'Nerve excitability changes in chronic renal failure indicate membrane depolarization due to hyperkalaemia', Brain, 125, pp. 1366 - 1378, http://dx.doi.org/10.1093/brain/awf123

Back to profile page